Emergent Biosolutions Inc/ US29089Q1058 /
| 2024-05-10 10:10:00 PM | Chg. -0.02 | Volume | Bid11:35:35 PM | Ask11:35:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.35USD | -0.46% | 1.38 mill. Turnover: 5.5 mill. |
4.35Bid Size: 2,600 | 4.39Ask Size: 100 | 227.95 mill.USD | - | - |
GlobeNewswire
05-10
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
GlobeNewswire
05-06
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire
05-01
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
GlobeNewswire
05-01
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Acces...
GlobeNewswire
04-22
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on M...
GlobeNewswire
04-01
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
GlobeNewswire
03-28
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray...
GlobeNewswire
03-25
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GlobeNewswire
03-20
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire
02-29
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conf...
GlobeNewswire
02-29
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire
02-21
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
GlobeNewswire
01-11
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (...
GlobeNewswire
01-09
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11,...
GlobeNewswire
2023-11-28
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ ...
GlobeNewswire
2023-11-24
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
GlobeNewswire
2023-10-30
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference...
GlobeNewswire
2023-10-19
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on...
GlobeNewswire
2023-10-02
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
